mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.02 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.02 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |